Novartis logo

Breaking News: FDA Approves Treatment for pNET Patients

May 5, 2011

For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients!  The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients.  This is a milestone for the carcinoid/NET…

READ MORE
Zebra Hair Dryer, Hot Tools

All Things Zebra for Carcinoid and Neuroendocrine Tumor Awareness

April 24, 2011

At the Carcinoid Cancer Foundation we get many inquiries about where to purchase zebra-striped pins and other awareness items.  We have scoured the Internet to share a wide variety of jewelry, party supplies, note cards, luggage, organizers, and everyday…

READ MORE
novartis-oncology-logo

Carcinoid Cancer Foundation Thanks Symposium Sponsors

April 21, 2011

There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual  symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City.  The Foundation…

READ MORE
Multidisciplinary Team at Bad Berka

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

April 5, 2011

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

READ MORE
Mayo Clinic banner

Multiple Endocrine Neoplasia (MEN) Seminar Scheduled for September 2011 at Mayo Clinic

April 4, 2011

SPECIAL NOTE:  This seminar has been cancelled but may be rescheduled at a later date in a different format.  We will post any updates we  receive.

__________________________________________________________________

MEN, carcinoid, and neuroendocrine…

READ MORE
CNETS Halifax 2011 Conference

CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals

April 1, 2011

Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…

READ MORE
FDA logo

Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting

March 24, 2011

Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …

READ MORE
Alex Todd-Lippock and Lisa Todd

Carcinoid Patient’s Stepdaughter Runs in Sun Trust National Marathon in Support of Carcinoid Cancer Foundation

March 23, 2011

If you are in Washington, D.C. on Saturday, March 26th cheer on Alex Todd-Lippock, bib number 3029, when she runs in the 2011 Sun Trust National Marathon in support of the Carcinoid Cancer Foundation (CCF). Ms. Todd-Lippock’s stepmother, Lisa Todd, is…

READ MORE
GlucoMedix

RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients

March 23, 2011

Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund.  According to Ebrahim

READ MORE
_DSC2397 copyW_OutshadowSharp

Carcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel

March 5, 2011

What are the most state-of-the-art treatments for carcinoid and NET cancer patients today?  Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized

READ MORE